Demystifying Cloud in the Enterprise
Though evidence abounds of cloud computing moving from the hype stage to successful adoption and deployment, many enterprises are still not clear on how to adopt cloud and make it part of their enterprise IT strategies. This is in part due to a misperception about what cloud computing is and the number of myths that still exist today about the cloud.
Read more on E-Commerce Times
Cell Therapeutics Files Appeal on FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed …
Cell Therapeutics, Inc. today announced that it has submitted a formal appeal to the Office of New Drugs in the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research regarding the agency’s decision from earlier this year on the pixantrone New Drug Application to treat relapsed/refractory aggressive non-Hodgkin’s lymphoma .
Read more on PR Newswire via Yahoo! Finance
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid …
About 50% of patients (age ≥60 years) who have acute myeloid leukaemia and are otherwise medically healthy (ie, able to undergo intensive chemotherapy) achieve a complete remission (CR) after intensive chemotherapy, but with a substantially increased risk of early death (ED) compared with younger patients.
Read more on Lancet